miércoles, 1 de julio de 2015

MCMi annual program update - CBRN, Ebola, research + more

FDA Medical Countermeasures Initiative Update

FDA MCMi Annual Program Update

MCMi FY14 Program Update cover

From FDA Acting Chief Scientist Dr. Luciana Borio:
I am pleased to present the FDA Medical Countermeasures Initiative (MCMi) program update for our fourth year of operations.  In addition to our ongoing work to advance the development and availability of medical countermeasures to protect against chemical, biological, radiological, and nuclear (CBRN) threats, we have also responded to emerging public health threats in an unprecedented way.
The Ebola epidemic in West Africa tested systems we’ve been putting in place since MCMi was launched in 2010, including new legal authorities granted by the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA); numerous collaborations with industry, academia, government and international partners; and our investments in regulatory science research—research required to facilitate the development of medical countermeasures and inform their use in emergency situations. more

Related information

News updates

Preparedness and response: 
  • The HHS Assistant Secretary for Preparedness and Response (ASPR) has introduced a new resource, the ASPR Technical Resources Assistance Center and Information Exchange (ASPR TRACIE), a new information gateway that connects public health and medical professionals with the emergency preparedness, response and recovery information they need. (June 15, 2015)
Federally funded research:
Deadline reminders:
  • The National Library of Medicine announced a funding opportunity for small projects to improve access to disaster medicine and public health information for health care professionals, first responders and others that play a role in health-related disaster preparedness, response and recovery. Proposals due July 6, 2015.
  • HHS intends to hold a prize competition for the delivery of one or more successful rapid point-of-care diagnostics that may be used by health care providers to identify bacterial infections. NIH and BARDA are sponsoring the prize competition, and seek public comments regarding the technical criteria and performance characteristics of the diagnostic(s) for which the prize(s) will be offered. Comment by July 17, 2015.
  • FDA funds external organizations through its Broad Agency Announcement (BAA) for theAdvanced Research and Development of Regulatory Science. We are currently accepting BAA responses until February 19, 2016Learn more and view current projects

No hay comentarios: